National Policy on Traditional Medicine and Regulation of Herbal Medicines - Report of a WHO Global Survey
(2005; 168 pages) Voir le document au format PDF
Table des matières
Afficher le documentAcknowledgements
Afficher le documentExecutive summary
Afficher le documentAcronyms, abbreviations and definitions
Afficher le documentWHO Regions
Ouvrir ce répertoire et afficher son contenu1. Introduction
Ouvrir ce répertoire et afficher son contenu2. National policy on traditional medicine and complementary/alternative medicine
Fermer ce répertoire3. The regulatory situation of herbal medicines
Afficher le document3.1 Law or regulation on herbal medicines
Afficher le document3.2 Regulatory status of herbal medicines
Afficher le document3.3 Claims
Afficher le document3.4 Pharmacopoeias
Afficher le document3.5 Monographs on herbal medicines
Afficher le document3.6 Manufacture of herbal medicines
Afficher le document3.7 Safety and herbal medicines
Afficher le document3.8 Registration system for herbal medicines
Afficher le document3.9 Herbal medicines and the essential drug list
Afficher le document3.10 Post marketing surveillance of herbal medicines
Afficher le document3.11 The sale of herbal medicines
Afficher le document3.12 Annual market sales of herbal medicines
Ouvrir ce répertoire et afficher son contenu4. Member States, WHO and herbal medicines
Ouvrir ce répertoire et afficher son contenu5. Country summaries
Afficher le documentReferences
Afficher le documentAnnex 1. Text of survey instrument
 

3.12 Annual market sales of herbal medicines

In the final question in this section related to the regulation of herbal medicines, countries were asked to provide data about annual market sales for herbal medicine for the most recent three years. The question also asked for clarification of the source of the figures provided.

Thirty countries provided some data on annual market sales of herbal medicines. However, as the data were largely fragmentary, the compiled results represent the nine Member States that included data for the period 1999-2001. It includes Member States from all six WHO Regions, with varying levels of economic development. The data which were excluded from the compilation were not complete, or were not provided for the chosen period. Finally, some countries provided figures in terms of packs of tablets or bottles of tonics, but such figures are not comparable between countries.

The nine States included in the results below (Figure 42) are Bhutan, Canada, Czech Republic, Islamic Republic of Iran, Madagascar, Malaysia, Pakistan, Sudan and Sweden. When figures were given in local currency, they were converted to United States dollars, using the exchange rates published by the United Nations on 1 November 2003.

The data excluded from the compilation above provide further evidence of the rise in annual market sales of herbal medicine globally.


Figure 42. Annual market sales of herbal medicines in nine countries, 1999-2001

 

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 25 juin 2014